Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 1183-1189

  Li, Xue Yi ^a   Ding, Jin ^a   Zheng, Zhao Hui ^a   Li, Xiao Yan ^b   Wu, Zhen Biao ^a   Zhu, Ping ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Immunosuppressive ability; Mesenchymal stem cells; T cells

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL AGING; CELL PROLIFERATION; CELL STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NORMAL HUMAN; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BONE MARROW CELLS; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MALE; MESENCHYMAL STROMAL CELLS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84866451326     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1039     Document Type: Article

References (37)

1. Caplan AI: Mesenchymal stem cells. J Orthop Res 9: 641-650, 1991.
2. Deans RJ and Moseley AB: Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884, 2000.
3. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999. (Pubitemid 29282067)
4. Ferrari G, Cusella-De Angelis G, Coletta M, et al: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-1530, 1998. (Pubitemid 28217075)
5. Liechty KW, MacKenzie TC, Shaaban AF, et al: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6: 1282-1286, 2000.
6. Pereira RF, O'Hara MD, Laptev AV, et al: Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95: 1142-1147, 1998. (Pubitemid 28124926)
7. Di Nicola M, Carlo-Stella C, Magni M, et al: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843, 2002. (Pubitemid 34534559)
8. Krampera M, Glennie S, Dyson J, et al: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729, 2003. (Pubitemid 36857965)
9. Aggarwal S and Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822, 2005. (Pubitemid 40223708)
10. Bartholomew A, Sturgeon C, Siatskas M, et al: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48, 2002. (Pubitemid 34059216)
11. Le Blanc K, Rasmusson I, Sundberg B, et al: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441, 2004. (Pubitemid 38586721)
12. Zappia E, Casazza S, Pedemonte E, et al: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761, 2005. (Pubitemid 41208591)
13. Zheng ZH, Li XY, Ding J, Jia JF and Zhu P: Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology (Oxford) 47: 22-30, 2008. (Pubitemid 350286256)
14. Chen FH and Tuan RS: Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 10: 223, 2008.
15. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ and Bellantuono I: Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22: 675-682, 2004. (Pubitemid 39172200)
16. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A and Nikbin B: Aging of mesenchymal stem cell in vitro. BMC Cell Biol 71: 4, 2006.
17. Weyand CM and Goronzy JJ: Stem cell aging and autoimmunity in rheumatoid arthritis. Trends Mol Med 10: 426-433, 2004. (Pubitemid 39209208)
18. Morimoto D, Kuroda S, Kizawa T, et al: Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis. Rheumatology (Oxford) 48: 643-649, 2009.
19. Kassem M, Ankersen L, Eriksen EF, Clark BF and Rattan SI: Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporos Int 7: 514-524, 1997. (Pubitemid 28009011)
20. Dimri GP, Lee X, Basile G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367, 1995.
21. Groh ME, Maitra B, Szekely E and Koc ON: Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33: 928-934, 2005. (Pubitemid 40982660)
22. Le Blanc K, Rasmusson I, Gotherstrom C, et al: Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60: 307-315, 2004. (Pubitemid 39141263)
23. Zhu P, Li XY, Wang HK, et al: Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Clin Immunol 122: 75-84, 2007. (Pubitemid 46026693)
24. Fridenshtein A, Petrakova KV, Kuralesova AI and Frolova GI: Precursor cells for osteogenic and hemopoietic tissues. Analysis of heterotopic transplants of bone marrow. Tsitologiia 10: 557-567, 1968.
25. Lu L, Zhao C, Liu Y, et al: Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res 15: 46-51, 2005. (Pubitemid 40616871)
26. Studeny M, Marini FC, Dembinski JL, et al: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603, 2004. (Pubitemid 39534883)
27. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2: 83-92, 1974.
28. Dressler MR, Butler DL and Boivin GP: Effects of age on the repair ability of mesenchymal stem cells in rabbit tendon. J Orthop Res 23: 287-293, 2005. (Pubitemid 40287851)
29. Liu L, DiGirolamo CM, Navarro PA, Blasco MA and Keefe DL: Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res 294: 1-8, 2004. (Pubitemid 38229774)
30. Stolzing A and Scutt A: Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5: 213-224, 2006. (Pubitemid 43809939)
31. Zheng H, Martin JA, Duwayri Y, Falcon G and Buckwalter JA: Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J Gerontol A Biol Sci Med Sci 62: 136-148, 2007. (Pubitemid 47065737)
32. Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, et al: Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36: 1014-1021, 2008.
33. Zohar R, Sodek J and McCulloch CA: Characterization of stromal progenitor cells enriched by flow cytometry. Blood 90: 3471-3481, 1997. (Pubitemid 27473417)
34. Matsubara T, Tsutsumi S, Pan H, et al: A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun 313: 503-508, 2004. (Pubitemid 38021856)
35. Schallmoser K, Rohde E, Reinisch A, et al: Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue engineering 14: 185-196, 2008.
36. Hung SC, Yang DM, Chang CF, et al: Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. Int J Cancer 110: 313-319, 2004.
37. Shi S, Gronthos S, Chen S, et al: Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20: 587-591, 2002. (Pubitemid 34595152)